Enriching People’s Lives Through Education of Healthcare Practitioners Articles

Back

CoronaVac, developed by Sinovac, is one of the most widely used COVID-19 vaccines. With more than two billion doses delivered globally, it was the first official vaccine to arrive in Hong Kong in 2021 and has been one of the two official vaccines adopted under the COVID-19 Vaccination Program in the market.

Recognizing the importance to expand the vaccine’s awareness and coverage across the healthcare sector in Hong Kong, DKSH partnered with Sinovac to strengthen the scientific education of doctors and healthcare practitioners on the vaccine.

Besides reaching out and enhancing the education of local healthcare and medical practitioners about the importance of vaccination, the program also aided to provide updates on the latest research and clinical trials made of CoronaVac, using COVID-19 variants, booster doses, age extension into the pediatric population, and other segments.

At DKSH, our purpose is to enrich people’s lives. We do so by providing reliable access to high-quality and responsible products and services, creating sustainable value for our partners, and contributing to raising the quality of life in the communities we operate in by generating jobs, perspectives, and opportunities for people’s development and growth.